| An Insight into the Health Benefits of Sodium Alginate and its Derivatives L Sharifi, MR Nowroozi, S Bokaie, G Smirnova, A Fedotova, D Babarykin, ... Biomedical Journal of Scientific & Technical Research 55 (3), 46971-46979, 2024 | | 2024 |
| Analysis of Lymphocyte and Clinical Profile in Nonmonogenic Common Variable Immunodeficiency Patients With and Without Class Switch Recombination Defect FT Zavareh, A Mirshafiey, R Yazdani, AA Keshtkar, H Abolhassani, ... Journal of investigational allergology & clinical immunology 33 (6), 474-476, 2023 | | 2023 |
| The Open, Randomized, Positive Control Clinical Trial of Guluronic Acid (G2013) on SARS-CoV-2 Patients Z Aghazadeh, D Sanaee Delir, HR Gholamrezaie, A Sadoughi, ... Current Drug Discovery Technologies 20 (4), 55-62, 2023 | | 2023 |
| The immunomodulatory effects of all-trans retinoic acid and docosahexaenoic acid combination treatment on the expression of IL-2, IL-4, T-bet, and GATA3 genes in PBMCs of … AM Nasl-Khameneh, A Mirshafiey, AN Moghadasi, MS Yekaninejad, ... Neurological Research 45 (6), 510-519, 2023 | 1 | 2023 |
| The Efficacy of Two Specific Toll-Like Receptor 4 Antagonists (G2013 & M2000) In Clinical Inflammatory Disease M Taeb, M Rahmani, L Sharifi, A Mirshafiey Applied Sciences Research Periodicals 1 (2), 11-30, 2023 | | 2023 |
| Evaluation of cell adhesion molecules (LFA-1 and L-selectin) in ankylosing spondylitis patients after treatment with β-D-mannuronic acid (M2000) MJ Fattahi, BHA Rehm, H Matsuo, S Cuzzocrea, F Jafarnezhad-Ansariha, ... Indian Journal of Medical Research 157 (5), 453-459, 2023 | | 2023 |
| Evaluation of the Effect of α-L-Guluronic Acid (G2013), as a New Member of NSAID Family, on Expression Pattern of Chemokine Receptors in Systemic Lupus Erythematosus A Mirshafiey Biomedical Journal of Scientific & Technical Research 52 (4), 43931-43940, 2023 | | 2023 |
| Evaluation of cell adhesion molecules (LFA-1 and L-selectin) in ankylosing spondylitis patients after treatment with?-D-mannuronic acid (M2000) J Fattahi Mohammad, BHA Rehm, H Matsuo, S Cuzzocrea, ... | | 2023 |
| Safety Assessment for Mannuronic and Guluronic Acids, as Alginate Residues in Toxicology Studies M Taeb, A Razavi, A Mirshafiey Biomedical Journal of Scientific & Technical Research 49 (1), 40224-40231, 2023 | | 2023 |
| Effects of β-D-Mannuronic Acid on TLR2 and TLR4 Expression and Associated Downstream Signaling in Monocyte-Derived Macrophages in Ankylosing Spondylitis Patients A Mirshafiey Biomedical Journal of Scientific & Technical Research 48 (2), 39468-39480, 2023 | | 2023 |
| The genes expression status of inflammatory determinants following the oral administration of Mannuronic acid in patients with rheumatoid arthritis S Omidian, A Ahmadzadeh, Z Rezaieyazdi, H Soleymani-Salehabadi, ... Medical Research Journal 8 (1), 41-49, 2023 | | 2023 |
| Analysis of Lymphocyte and Clinical Profile among Non-monogenic Common Variable Immunodeficiency Patients with and without Class Switch Recombination Defect A Mirshafiey, A Aghamohammadi J Investig Allergol Clin Immunol 33 (6), 2023 | | 2023 |
| β-D-mannuronic Acid (M2000) and Inflammatory Cytokines in COVID-19; An in vitro Study B Robat-Jazi, K Ghorban, M Gholami, E Samizadeh, Z Aghazadeh, ... Iranian Journal of Allergy, Asthma and Immunology, 2022 | 2 | 2022 |
| Digging for the discovery of SARS-CoV-2 nsp12 inhibitors: a pharmacophore-based and molecular dynamics simulation study FS Askari, M Ebrahimi, J Parhiz, M Hassanpour, A Mohebbi, A Mirshafiey Future Virology 17 (10), 743-759, 2022 | 9 | 2022 |
| Immunophenotypic and functional analysis of lymphocyte subsets in common variable immunodeficiency patients without monogenic defects F Tofighi Zavareh, A Mirshafiey, R Yazdani, AA Keshtkar, H Abolhassani, ... Scandinavian Journal of Immunology 96 (1), e13164, 2022 | 11 | 2022 |
| The Effects of Mannuronic Acid on IL‐1β, IL‐17A, STAT1, and STAT3 Gene Expressions and TLR2 and TLR4 Molecules in Multiple Sclerosis S Najafi, P Saadat, N Beladi Moghadam, A Manoucherinia, Z Aghazadeh, ... The Journal of Clinical Pharmacology 62 (6), 762-769, 2022 | 3 | 2022 |
| A controlled, randomized phase II clinical trial for efficacy and safety evaluation of mannuronic acid in secondary progressive form of multiple sclerosis S Najafi, NB Moghadam, P Saadat, SM Noorbakhsh, AV Mohammadi, ... International Journal of Neuroscience 132 (4), 403-412, 2022 | 5 | 2022 |
| Evaluating mannuronic acid effect on gene expression profile of inflammatory mediators in rheumatoid arthritis patients S Omidian, Z Aghazadeh, A Ahmadzadeh, M Aslani, M Hosseini, ... Iranian Journal of Allergy, Asthma and Immunology, 2022 | 2 | 2022 |
| Evaluation of G2013 (α‐L‐guluronic acid) efficacy on PC‐3 cells through inhibiting the expression of inflammatory factors Z Bagherian, A Mirshafiey, M Mohsenzadegan, MM Farajollahi Clinical and Experimental Pharmacology and Physiology 49 (2), 254-263, 2022 | 3 | 2022 |
| Tau and amyloid beta differentially affect the innate immune genes expression in Drosophila models of Alzheimer’s disease and β-D Mannuronic acid (M2000) modulates the … A Barati, R Masoudi, R Yousefi, M Monsefi, A Mirshafiey Gene 808, 145972, 2022 | 6 | 2022 |
